2,6-Difluorobenzenesulfonyl chloride is used as a reagent to synthesize Dabrafenib, an inhibitor of BRAF kinase that is used to treat BRAF V600-mutation positive carcinoma. BRAF is a gene that mediates cell growth and is activated by mutations caused by cancer. 2,6-Difluorobenzenesulfonyl chloride is also a potential inhibitor of zinc proteases.
危险品:
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
您的位置：
